---
layout: post
title: "Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea; Public Workshop; Request for Comments"
date: 2026-02-05 19:09:12 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-07548
original_published: 2021-04-13 00:00:00 +0000
significance: 8.00
---

# Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea; Public Workshop; Request for Comments

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 13, 2021 00:00 UTC
**Document Number:** 2021-07548

## Summary

The Food and Drug Administration (FDA, Agency, or we), the National Institute of Allergy and Infectious Diseases (NIAID), and the Centers for Disease Control and Prevention (CDC) are announcing the following public workshop entitled "Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea." The purpose of the public workshop is to discuss the nonclinical and clinical pharmacology data and clinical trial design considerations regarding developing antimicrobial drugs for the treatment of gonorrhea.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/04/13/2021-07548/development-considerations-of-antimicrobial-drugs-for-the-treatment-of-gonorrhea-public-workshop)
- API: https://www.federalregister.gov/api/v1/documents/2021-07548

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
